NEW YORK, May 19, 2011 /PRNewswire/ — Enhanced Equity Fund
(EEF), a healthcare-focused private equity firm, and executive
James White announced their investment in MedTest DX, Inc.
(MedTest), a medical diagnostic company based in Cortlandt Manor,
NY. MedTest was created to purchase the chemistry diagnostics
business from Polymedco, Inc. The transaction was led by Mark
Tricolli, a Partner of EEF. Terms were not disclosed.
“EEF is committed to building a leading platform in the medical
diagnostics industry and our investment in MedTest represents an
attractive initial asset from which to grow both organically and
through acquisitions,” said Mr. Tricolli. He added, “We are
excited to partner with James White, who has a proven track record
in this industry, and provide capital for future growth
initiatives.”
James White, Chief Executive Officer of MedTest said, “EEF’s
investment in our chemistry assets represents a tremendous
opportunity for MedTest to build on the company’s strong reputation
with its customers and suppliers in the marketplace. Both EEF
and MedTest share the same philosophy of delivering superior
products and service and we are truly excited to join forces to
capitalize on numerous growth opportunities.”
About MedTest DX
MedTest was founded in 2011 and is based in Cortlandt Manor, NY.
The company sells a range of chemistry instruments, reagents,
and instrument service to physician offices, hospitals, reference
laboratories, and research facilities, both direct and through
distribution channels in the U.S. MedTest DX products include
SPOTCHEM EZ, a compact benchtop dry chemistry analyzer that can run
single and panel diagnostic tests with results available in 8-15
minutes. In addition, the Poly-Chem 90 and 180 chemistry
analyzers offer countertop instruments to run chemistry tests,
including an integrated electrolyte module, data management and
over 70 FDA cleared rea
‘/>”/>
